Dr. Eva Morava-Kozicz, MD, PhD
Claim this profileStudies Congenital Disorder of Glycosylation
Studies Phosphomannomutase 2 Deficiency
1 reported clinical trial
2 drugs studied
More about Eva Morava-Kozicz, MD, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Eva Morava-Kozicz, MD, PhD has experience with
- Epalrestat
- Placebo
Breakdown of trials Eva Morava-Kozicz, MD, PhD has run
Congenital Disorder of Glycosylation
Phosphomannomutase 2 Deficiency
Phosphomannomutase II Deficiency
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eva Morava-Kozicz, MD, PhD specialize in?
Eva Morava-Kozicz, MD, PhD focuses on Congenital Disorder of Glycosylation and Phosphomannomutase 2 Deficiency. In particular, much of their work with Congenital Disorder of Glycosylation has involved PMM2 positive patients, or patients who are undergoing treatment.
Is Eva Morava-Kozicz, MD, PhD currently recruiting for clinical trials?
No, Eva Morava-Kozicz, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Eva Morava-Kozicz, MD, PhD has studied deeply?
Yes, Eva Morava-Kozicz, MD, PhD has studied treatments such as Epalrestat, Placebo.
What is the best way to schedule an appointment with Eva Morava-Kozicz, MD, PhD?
Apply for one of the trials that Eva Morava-Kozicz, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.